# ğŸ§¬ Putative Disease Gene Identification & Drug Repurposing for Steatohepatitis 
----------

ğŸ‘¥ Authors: Milad Torabi, Possenti Francesca  
ğŸ”¹ Sapienza University, Bioinformatics and Network Medicine  
ğŸ“… January 16, 2025    

-----------

 ğŸ“ Overview:  
Non-alcoholic steatohepatitis (NASH) is a complex liver disorder characterized by fat accumulation, inflammation, and hepatocellular injury. As the prevalence of NASH rises globally, there is an urgent need to identify putative disease genes and explore potential drug repurposing strategies. This project utilizes network science methods and bioinformatics algorithms to analyze NASH-related genes and repurpose existing drugs as potential therapeutic candidates.

----------

ğŸš€ Our goal: Identify putative disease genes & explore drug repurposing using network-based algorithms.

ğŸ¯ Project Objectives  
ğŸ”¬ Disease Gene Identification:  
- Identify putative disease-associated genes using PPI network analysis.   
- Utilize network-based algorithms (DIAMOnD, DIAble, Diffusion) to identify key genes related to NASH.    
- Integrate multi-omics data (proteomics and genomics) to explore disease mechanisms.    
- Implement drug repurposing strategies by screening approved drugs against the identified genes.   
- Provide insights into novel therapeutic avenues for NASH treatment.  


ğŸ’Š 4. Drug Repurposing Approach:  
âœ… Screen FDA-approved drugs  
âœ… Identify potential therapeutic candidates  
âœ… Accelerate the drug discovery process  
 

ğŸ›  Methodology & Workflow:   

ğŸ“¥ Step 1: Data Collection  
ğŸ“Œ Protein-Protein Interaction (PPI) Network: Retrieved from BioGRID database.  
ğŸ“Œ Gene-Disease Associations (GDAs): Extracted from DisGeNET (Disease Code: C2711227).  

ğŸ•¸ Step 2: Network Construction & Analysis  
ğŸ“Œ Built PPI network from BioGRID interactome.  
ğŸ“Œ Filtered data to include only human physical interactions.  
ğŸ“Œ Identified the largest connected component (LCC) within the network.  

ğŸ§ª Step 3: Disease Gene Identification  
ğŸ“Œ Applied DIAMOnD, DIAble, and Diffusion algorithms to identify putative disease genes.  
ğŸ“Œ Prioritized genes based on their connectivity and biological relevance.  

ğŸ’Š Step 4: Drug Repurposing  
ğŸ“Œ Mapped identified genes to known drug-target interactions.   
ğŸ“Œ Screened FDA-approved drugs for potential efficacy against NASH-related pathways.   

ğŸ— Tech Stack & Tools
ğŸ–¥ Programming Language: Python  
ğŸ“š Libraries: pandas, numpy, networkx, matplotlib, seaborn  
ğŸ—„ Databases: BioGRID and DisGeNET databases for gene and interaction data  
ğŸ“Š Algorithms: DIAMOnD, DIAble, Diffusion(Graph-based algorithms for network analysis)  

ğŸ“Š Results & Insights  
âœ” Identified key genes potentially involved in NASH pathogenesis.  
âœ” Mapped existing drugs for repurposing  
âœ” Contributed to advancing bioinformatics-driven approaches for liver disease research  

ğŸ” Potential Impact:  
ğŸš€ Accelerates drug discovery  
ğŸ©º Provides therapeutic targets  
ğŸ”¬ Advances precision medicine for NASH  

ğŸ”® Future Work  
ğŸ”¹ Expand datasets with multi-omics data  
ğŸ”¹ Validate findings via experimental studies  
ğŸ”¹ Incorporate deep learning for better gene-disease association predictions  
